ARMEN GARO H 4

What Happened

• Garo H. Armen, Chairman, Chief Executive Officer and Principal Financial Officer of Agenus Inc. (AGEN), was issued 4,629 shares as compensation (an award/acquisition) for the pay period ending April 3, 2026.
• The shares were valued at $3.33 each (closing price on April 2, 2026), for a total reported value of approximately $15,415. The shares are fully vested on the date of issuance.

Key Details

• Transaction date: April 3, 2026; Price used: $3.33 per share (closing price April 2, 2026).
• Type: Award/acquisition in lieu of cash salary (reported as stock compensation).
• Shares held after transaction: not specified in the filing.
• Notable footnotes: shares are issued per the company’s 2019 Equity Incentive plan and are fully vested; reported amount is the net salary for the pay period; shares are held in Dr. Armen’s IRA accounts.
• Related holdings disclosed: Dr. Armen is trustee and has investment authority for a GRAT holding 23,950 shares and is a general partner in Pixie Partners, which owns 5,000 shares (he disclaims beneficial ownership to the extent of his pecuniary interest).
• Filing timeliness: the report was filed April 6, 2026 for an April 3, 2026 transaction; the filing does not indicate a late-report designation.

Context

• This was compensation paid in stock, not an open‑market purchase or sale. Such issuances reflect how the company and executive agreed to receive pay (salary conversion) and are routinely used for cash conservation or tax planning; they do not necessarily signal a personal buy or sell decision.